Lunasin induces apoptosis and modifies the expression of genes associated with extracellular matrix and cell adhesion in human metastatic colon cancer cells

Molecular Nutrition and Food Research

Volumn 55, Issue 4, 2011, Pages 623-634

  Dia, Vermont P ^a   De Mejia, Elvira Gonzalez ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

5 1 Integrin; Apoptosis; Colon cancer; Lunasin; Metastatic

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE; CELL ADHESION MOLECULE; CELL CYCLE PROTEIN; GM2S 1 PROTEIN, GLYCINE MAX; GM2S-1 PROTEIN, GLYCINE MAX; OXALIPLATIN; PLATINUM COMPLEX; SCLEROPROTEIN; SOYBEAN PROTEIN; VERY LATE ACTIVATION ANTIGEN 5;

APOPTOSIS; ARTICLE; CELL CYCLE G2 PHASE; CELL SURVIVAL; COLORECTAL TUMOR; DRUG EFFECT; DRUG RESISTANCE; ENZYME ACTIVATION; GENE EXPRESSION PROFILING; GENETICS; HUMAN; IC 50; METABOLISM; MITOCHONDRION; PATHOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CASPASES; CELL ADHESION MOLECULES; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL SURVIVAL; COLORECTAL NEOPLASMS; DRUG RESISTANCE, NEOPLASM; ENZYME ACTIVATION; EXTRACELLULAR MATRIX PROTEINS; G2 PHASE; GENE EXPRESSION PROFILING; HUMANS; INHIBITORY CONCENTRATION 50; INTEGRIN ALPHA5BETA1; MITOCHONDRIA; ORGANOPLATINUM COMPOUNDS; SOYBEAN PROTEINS;

EID: 79953319182     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201000419     Document Type: Article

References (49)

1. Galvez, A. F., de Lumen, B. O., A soybean cDNA encoding a chromatin-binding peptide inhibits mitosis of mammalian cells. Nat. Biotechnol. 2006, 17, 495-500.
2. Silva-Sanchez, C., dela Rosa, A. P. B., Leon-Galvan, M. F., de Lumen, B. O., Gonzalez de Mejia, E., Bioactive peptides from amaranth (Amaranthus hypochondriacus) seed. J. Agric. Food Chem. 2008, 56, 1233-1240.
3. Jeong, H. J., Lam, Y., de Lumen, B. O., Barley lunasin suppresses ras-induced colony formation and inhibits core histone acetylation in mammalian cells. J. Agric. Food Chem. 2002, 50, 5903-5908.
4. Jeong, J. B., Jeong, H. J., Park, J. H., Lee, S. H. et al., Cancer-preventive peptide lunasin from Solanum nigrum L. inhibits acetylation of core histones H3 and H4 and phosphorylation of retinoblastoma protein (Rb). J. Agric. Food Chem. 2007, 55, 10707-10713.
5. Jeong, H. J., Jeong, J. B., Kim, D. S., Park, J. H. et al., The cancer preventive peptide lunasin from wheat inhibits core histone acetylation. Cancer Lett. 2007, 255, 42-48.
6. Dia, V. P., Wang, W., Oh, V. L., de Lumen, B. O., Gonzalez de Mejia, E., Isolation, purification and characterisation of lunasin from defatted soybean flour and in vitro evaluation of its anti-inflammatory activity. Food Chem. 2009, 114, 108-115.
7. Gonzalez de Mejia, E., Dia, V. P., Lunasin and lunasin-like peptides inhibit inflammation through suppression of NF-κB pathway in the macrophage. Peptides 2009, 30, 2388-2398.
8. Hernandez-Ledesma, B., Hsieh, C. C., de Lumen, B. O., Antioxidant and anti-inflammatory properties of cancer preventive peptide lunasin in RAW 264.7 macrophages. Biochem. Biophys. Res. Commun. 2009, 390, 803-808.
9. Gonzalez de Mejia, E., Wang, W., Dia, V. P., Lunasin, with an arginine-glycine-aspartic acid motif, causes apoptosis to L1210 leukemia cells by activation of caspase-3. Mol. Nutr. Food Res. 2010, 54, 406-414.
10. Dia, V. P., de Mejia, E. G., Lunasin promotes apoptosis in human colon cancer cells by mitochondrial pathway activation and induction of nuclear clusterin expression. Cancer Lett. 2010, 295, 44-53.
11. Hsieh, C. C., Hernandez-Ledesma, B., Jeong, H. J., Park, J. H., de Lumen, B. O., Complementary roles in cancer prevention: protease inhibitor makes the cancer preventive peptide lunasin bioavailable. PLoS One 2010, 5, e8890, DOI: 10.1371/journal.pone.0008890.
12. Galvez, A. F., Chen, N., Macasieb, J., de Lumen, B. O., Chemopreventive property of a soybean peptide (lunasin) that binds to deacetylated histones and inhibits acetylation. Cancer Res. 2001, 61, 7473-7478.
13. Anuradha, C. D., Kanno, S., Hirano, S., RGD peptide-induced apoptosis in human leukemia HL-60 cells required caspase-3 activation. Cell Biol. Toxicol. 2000, 16, 275-283.
14. Matsuki, K., Sasho, T., Nakagawa, K., Tahara, M. et al., RGD peptide-induced cell death of chondrocytes and synovial cells. J. Orthop. Sci. 2008, 13, 524-532.
15. Wyllie, A. H., Beattie, G. J., Hargreaves, A. D., Chromatin changes in apoptosis. Histochem. J. 1981, 13, 681-692.
16. Wyllie, A. H., Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980, 284, 555-556.
17. Hanahan, D., Weinberg, R. A., The hallmarks of cancer. Cell 2000, 100, 57-70.
18. Jemal, A., Siegel, R., Ward, E., Hao, Y. P. et al., Cancer statistics, 2009. CA Cancer J. Clin. 2000, 59, 225-249.
19. Yabroff, K. R., Mariotto, A. B., Feuer, E., Brown, M. L., Projections of costs associated with colorectal cancer in the United States, 2000-2020. Health Econ. 2008, 17, 947-959.
20. Wilson, P. M., LaBonte, M. J., Lenz, H. J., Molecular markers in the treatment of metastatic colorectal cancer. Cancer J. 2010, 16, 262-272.
21. Gourdier, I., Del Rio, M., Crabbe, L., Candeil, L. et al., Drug specific resistance to oxaliplatin is associated with apoptosis defect in a cellular model of colon carcinoma. FEBS Lett. 2002, 529, 232-236.
22. Mishima, M., Samimi, G., Kondo, A., Lin, X., Howell, S. B., The cellular pharmacology of oxaliplatin resistance. Eur. J. Cancer 2002, 38, 1405-1412.
23. Eng, C., Toxic effects and their management: daily clinical challenges in the treatment of colorectal cancer. Nat. Rev. Clin. Oncol. 2009, 6, 207-218.
24. Morikawa, K., Walker, S. M., Nakajima, M., Pathak, S. et al., Influence of organ environment on the growth, selection and metastasis of human colon carcinoma cells in nude mice. Cancer Res. 1988, 48, 6863-6871.
25. Yang, A. D., Fan, F., Ramsay Camp, E., van Buren, G. et al., Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines. Clin. Cancer Res. 2006, 12, 4147-4153.
26. Villard, V., Kalvuzhniv, O., Riccio, O., Potekhin, S. et al., Synthetic RGD-containing alpha-helical coiled coil peptides promote integrin-dependent cell adhesion. J. Pept. Sci. 2006, 12, 206-212.
27. Lu, X., Lu, D., Scully, M. F., Kakkar, V. V., Integrins in drug targeting-RGD templates in toxins. Curr. Pharm. Des. 2006, 12, 2749-2769.
28. 1 function with a small peptide (ATN-161) plus continuous 5-FU infusion reduces colorectal liver metastases and improves survival in mice. Int. J. Cancer 2003, 104, 496-503.
29. Garg, A., Tisdale, A. W., Haidari, E., Kokkoli, E., Targeting colon cancer cells using PEGylated liposomes modified with a fibronectin-mimetic peptide. Int. J. Pharm. 2009, 366, 201-210.
30. O'Brien, V., Frisch, S. M., Juliano, R. L., Expression of the integrin alpha 5 subunit in HT-29 colon carcinoma cells suppresses apoptosis triggered by serum deprivation. Exp. Cell Res. 1996, 224, 208-213.
31. 1 integrin in determining malignant properties of colon carcinoma cells. Cell Growth Differ. 1997, 8, 83-90.
32. Chen, X., Plasencia, C., Hou, Y., Neamiti, N., Synthesis and biological evaluation of dimeric RGD peptide-paclitaxel conjugate as a model for integrin-targeted drug delivery. J. Med. Chem. 2005, 48, 1098-1106.
33. Yang, W., Meng, L., Wang, H., Chen, R. et al., Inhibtion of proliferative and invasive capacities of breast cancer cells by ariginine-glycine-aspartic acid peptide in vitro. Oncol. Rep. 2006, 15, 113-117.
34. Abukhdeir, A. M., Vitolo, M. I, Argani, P., De Marzo, A. M. et al., Tamoxifen-stimulated growth of breast cancer due to p21 loss. Proc. Natl. Acad. Sci. USA 2008, 105, 288-293.
35. Chu, I., Sun, J., Arnaout, A., Kahn, H. et al., p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2. Cell 2007, 128, 281-294.
36. Mazzarelli, P., Pucci, S., Spagnoli, L. G., CLU and colon cancer. The dual face of CLU: from normal to malignant phenotype. Adv. Cancer Res. 2009, 105, 45-61.
37. Chen, T., Turner, J., McCarthy, S., Scaltriti, M. et al., Clusterin-mediated apoptosis is regulated by adenomatous polyposis coli and is p21 dependent but p53 independent. Cancer Res. 2004, 64, 7412-7419.
38. Aguzzi, M. S., Fortugno, P., Giampetri, C., Ragone, G. et al., Intracellular targets of RGDS peptide in melanoma cells. Mol. Cancer 2010, 9, 84.
39. Aguzzi, M. S., Giampietri, C., De Marchis, F., Padula, F. et al., RGDS peptide induces caspase-8 and caspase-9 activation in human endothelial cells. Blood 2004, 103, 4180-4187.
40. Buckley, C.-D., Pilling, D., Henriquez, N.-V., Parsonage, G. et al., RGD peptides induce apoptosis by direct caspase-3 activation. Nature 1999, 397, 534-539.
41. Adderley, S. R., Fitzgerald, D. J., Glycoprotein IIb/IIIa anatagonists induce apoptosis in rat cardiomyocytes by caspase-3 activation. J. Biol. Chem. 2000, 275, 5760-5766.
42. Hsieh, C. C., Hernandez-Ledesma, B., de Lumen, B. O., Lunasin, a novel seed peptide, sensitizes human breast cancer MDA-MB-231 cells to aspirin-arrested cell cycle and induced apoptosis. Chem. Biol. Interact. 2010, 186, 127-134.
43. Morris, M. R., Ricketts, C., Gentle, D., Abdulrahman, M. et al., Identification of candidate tumour suppressor genes frequently methylated in renal cell carcinoma. Oncogene 2010, 29, 2104-2117.
44. Schuppan, D., Cantaluppi, M. C., Becker, J., Veit, A. et al., Undulin, an extracellular matrix glycoprotein associated with collagen fibrils. J. Biol. Chem. 1990, 265, 8823-8832.
45. Kim, S., Kang, H. Y., Nam, E.-H., Choi, M.-S. et al., TMPRSS4 induces invasion and epithelial-mesenchymal transition through upregulation of integrin α5 and its signaling pathways. Carcinogenesis 2010, 31, 597-606.
46. Murillo, C. A., Rychahou, P. G., Evers, B. M., Inhibition of α5 integrin decreases PI3K activation and cell adhesion of human colon cancers. Surgery 2004, 136, 143-149.
47. Shi, W. D., Meng, Z. Q., Chen, Z., Lin, J. H. et al., Identification of liver metastasis-related genes in a novel human pancreatic carcinoma cell model by microarray analysis. Cancer Lett. 2009, 283, 84-91.
48. Van Themsche, C., Alain, T., Kossakowska, A. E., Urbanski, S. et al., Stromelysin-2 (matrix metalloproteinase 10) is inducible in lymphoma cells and accelerates the growth of lymphoid tumors. J. Immunol. 2004, 173, 3605-3611.
49. Dia, P. V., Torres, S., De Lumen, B. O., Erdman, J., Gonzalez de Mejia, E., Presence of lunasin in plasma of men after soy protein consumption. J. Agric. Food Chem. 2009, 57, 1260-1266.